Ignite Creation Date:
2025-12-24 @ 3:53 PM
Ignite Modification Date:
2026-01-13 @ 11:01 PM
Study NCT ID:
NCT05692492
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-03-19
First Post:
2022-12-25
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Randomized, Double-blind, Placebo-controlled Study of ZSP1601 in Adult Subjects With Nonalcoholic Steatohepatitis (NASH)
Sponsor:
Guangdong Raynovent Biotech Co., Ltd
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-06-03
Start Date Type:
ACTUAL
Primary Completion Date:
2026-06-16
Primary Completion Date Type:
ESTIMATED
Completion Date:
2026-12-16
Completion Date Type:
ESTIMATED
First Submit Date:
2022-12-25
First Submit QC Date:
None
Study First Post Date:
2023-01-20
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-03-18
Last Update Post Date:
2025-03-19
Last Update Post Date Type:
ACTUAL